Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

December 01, 1991; Volume 40,Issue 6
  • You have access
    Sequence and expression of a neuropeptide Y receptor cDNA.
    J Rimland, W Xin, P Sweetnam, K Saijoh, E J Nestler and R S Duman
    Molecular Pharmacology December 1991, 40 (6) 869-875;
  • You have access
    Solution-phase library screening for the identification of rare clones: isolation of an alpha 1D-adrenergic receptor cDNA.
    D M Perez, M T Piascik and R M Graham
    Molecular Pharmacology December 1991, 40 (6) 876-883;
  • You have access
    Clonidine-displacing substance from bovine brain binds to imidazoline receptors and releases catecholamines in adrenal chromaffin cells.
    S Regunathan, M P Meeley and D J Reis
    Molecular Pharmacology December 1991, 40 (6) 884-888;
  • You have access
    Purification of a [3H]dihydrotetrabenazine-binding protein from bovine adrenal medulla.
    M S Vincent and J A Near
    Molecular Pharmacology December 1991, 40 (6) 889-894;
  • You have access
    Molecular cloning and expression of the rat beta 3-adrenergic receptor.
    J G Granneman, K N Lahners and A Chaudhry
    Molecular Pharmacology December 1991, 40 (6) 895-899;
  • You have access
    Subtype-specific antibodies for muscarinic cholinergic receptors. I. Characterization using transfected cells and avian and mammalian cardiac membranes.
    C S Mayanil, R M Richardson and M M Hosey
    Molecular Pharmacology December 1991, 40 (6) 900-907;
  • You have access
    Subtype-specific antibodies for muscarinic cholinergic receptors. II. Studies with reconstituted chick heart receptors and the GTP-binding protein G(o).
    R M Richardson, C S Mayanil and M M Hosey
    Molecular Pharmacology December 1991, 40 (6) 908-914;
  • You have access
    Pharmacological evidence for the heterogeneity of atrial natriuretic factor-R1 receptor subtype.
    J Féthière and A De Léan
    Molecular Pharmacology December 1991, 40 (6) 915-922;
  • You have access
    Regulation of sarcoplasmic reticulum protein phosphorylation by localized cyclic GMP-dependent protein kinase in vascular smooth muscle cells.
    T L Cornwell, K B Pryzwansky, T A Wyatt and T M Lincoln
    Molecular Pharmacology December 1991, 40 (6) 923-931;
  • You have access
    Polypeptide toxins from the venoms of Old World and New World scorpions preferentially block different potassium channels.
    M P Blaustein, R S Rogowski, M J Schneider and B K Krueger
    Molecular Pharmacology December 1991, 40 (6) 932-942;
  • You have access
    Muscarinic receptors in canine colonic circular smooth muscle. I. Coexistence of M2 and M3 subtypes.
    L B Zhang, B Horowitz and I L Buxton
    Molecular Pharmacology December 1991, 40 (6) 943-951;
  • You have access
    Muscarinic receptors in canine colonic circular smooth muscle. II. Signal transduction pathways.
    L B Zhang and I L Buxton
    Molecular Pharmacology December 1991, 40 (6) 952-959;
  • You have access
    Reversal of doxorubicin resistance by hydrophobic, but not hydrophilic, forskolins.
    S Wadler and C P Yang
    Molecular Pharmacology December 1991, 40 (6) 960-964;
  • You have access
    Metal- and photo-induced cleavage of DNA by podophyllotoxin, etoposide, and their related compounds.
    H Sakurai, T Miki, Y Imakura, M Shibuya and K H Lee
    Molecular Pharmacology December 1991, 40 (6) 965-973;
  • You have access
    Decreased beta 2-adrenergic receptor mRNA expression in receptor-deficient S49 lymphoma cells.
    R J Hughes, M J Howard, J M Allen and P A Insel
    Molecular Pharmacology December 1991, 40 (6) 974-979;
  • You have access
    Theoretical studies on the histamine H2 receptor: construction of a receptor model based on the structural properties of dimaprit and N alpha-guanylhistamine.
    L Pardo, J Giraldo, M Martín and M Campillo
    Molecular Pharmacology December 1991, 40 (6) 980-987;
  • You have access
    Photoaffinity labeling of the brevetoxin receptor on sodium channels in rat brain synaptosomes.
    V L Trainer, W J Thomsen, W A Catterall and D G Baden
    Molecular Pharmacology December 1991, 40 (6) 988-994;
  • You have access
    Gamma-aminobutyric acidA receptor complexes in rat frontal cortex and spinal cord show differential responses to steroid modulation.
    K W Gee and N C Lan
    Molecular Pharmacology December 1991, 40 (6) 995-999;
  • You have access
    Mu-opioid receptor inhibition of calcium current: development of homologous tolerance in single SH-SY5Y cells after chronic exposure to morphine in vitro.
    C Kennedy and G Henderson
    Molecular Pharmacology December 1991, 40 (6) 1000-1005;
  • You have access
    Halothane inhibits agonist-induced inositol phosphate and Ca2+ signaling in A7r5 cultured vascular smooth muscle cells.
    J C Sill, C Uhl, S Eskuri, R Van Dyke and J Tarara
    Molecular Pharmacology December 1991, 40 (6) 1006-1013;
  • You have access
    Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition.
    M McKinney, J H Miller, V A Gibson, L Nickelson and S Aksoy
    Molecular Pharmacology December 1991, 40 (6) 1014-1022;
  • You have access
    Molecular mechanics and molecular dynamics studies of the intercalation of dynemicin-A with oligonucleotide models of DNA.
    M G Cardozo and A J Hopfinger
    Molecular Pharmacology December 1991, 40 (6) 1023-1028;
  • You have access
    Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17 beta-estradiol-induced glucose metabolism in MCF-7 human breast cancer cells: 13C nuclear magnetic resonance spectroscopy studies.
    T R Narasimhan, S Safe, H J Williams and A I Scott
    Molecular Pharmacology December 1991, 40 (6) 1029-1035;
  • You have access
    Expression and pharmacological characterization of a canine 5-hydroxytryptamine1D receptor subtype.
    J M Zgombick, R L Weinshank, M Macchi, L E Schechter, T A Branchek and P R Hartig
    Molecular Pharmacology December 1991, 40 (6) 1036-1042;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 40, Issue 6
1 Dec 1991
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics